[Eptifibatide blocks the increase in C-reactive protein concentration after coronary angioplasty].

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Revista Española de Cardiología

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 11852009
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Inflammation and thrombosis

  2003cited by this paper
• Inflammation and thrombosis: the clot thickens.

  2001cited by this paper
• Valor pronóstico de la determinación de la proteína C reactiva en la angina inestable

  2001cited by this paper
• [Prognostic value of the determination of C-reactive protein in unstable angina].

  2001cited by this paper
• C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women.

  2000influential reference
• The New England Journal

  2000cited by this paper
• Interferon-gamma and lipopolysaccharide potentiate monocyte tissue factor induction by C-reactive protein: relationship with age, sex, and hormone replacement treatment.

  2000cited by this paper
• [Ischemic cardiopathy: inflammation markers and the cardiovascular risk].

  1999cited by this paper
• Increased proinflammatory cytokines in patients with chronic stable angina and their reduction by aspirin.

  1999cited by this paper
• Enhanced inflammatory response to coronary angioplasty in patients with severe unstable angina.

  1999cited by this paper
• Cardiopatía isquémica: marcadores de inflamación y riesgo cardiovascular

  1999cited by this paper
• C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992.

  1999cited by this paper
• Elevated levels of C-reactive protein at discharge in patients with unstable angina predict recurrent instability.

  1999cited by this paper
• C-Reactive Protein Is a Potent Predictor of Mortality Independently of and in Combination With Troponin T in Acute Coronary Syndromes: A TIMI 11A Substudy

  1998cited by this paper
• Enhanced inflammatory response to coronary angioplasty in patients with severe unstable angina.

  1998cited by this paper
• EFFECT OF ANTITHROMBIN III SUPPLEMENTATION ON INFLAMMATORY RESPONSE IN PATIENTS WITH SEVERE SEPSIS

  1998cited by this paper
• C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: a TIMI 11A substudy. Thrombolysis in Myocardial Infarction.

  1998cited by this paper
• C-Reactive Protein, a Sensitive Marker of Inflammation, Predicts Future Risk of Coronary Heart Disease in Initially Healthy Middle-Aged Men

  1998cited by this paper
• Prognostic influence of increased fibrinogen and C-reactive protein levels in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease.

  1997cited by this paper
• Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Multiple Risk Factor Intervention Trial.

  1996cited by this paper
• The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina.

  1994cited by this paper
• Solid phase radioimmunoassays for human C-reactive protein.

  1981cited by this paper

• Inflammatory cytokine imbalance after coronary angioplasty: links with coronary atherosclerosis.

  2007cites this paper
• Comparison of C-reactive protein levels after coronary stenting with bare metal versus sirolimus-eluting stents.

  2005cites this paper
• Effects of tirofiban on acute systemic inflammatory response in elective percutaneous coronary interventions

  2004cites this paper
• Inflammation and Cardiovascular Risk: An Overview

  2004cites this paper
• Intravenous glycoprotein IIb/IIIa antagonists: their benefits, problems and future developments.

  2004cites this paper
• Comparison of effects of abciximab versus eptifibatide on C-reactive protein, interleukin-6, and interleukin-1 receptor antagonist after coronary arterial stenting.

  2003cites this paper
• Increase in Interleukin-6 in the First Hour after Coronary Stenting: An Early Marker of the Inflammatory Response

  2003cites this paper
• [Late T-lymphocyte and monocyte activation in coronary restenosis. Evidence for a persistent inflammatory/immune mechanism?].

  2003cites this paper